Newsroom

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced the appointment of Clare Kahn, Ph.D., to its Board of Directors. “Clare brings more than three decades of industry experience,...

MIAMI--(BUSINESS WIRE)--Arcadia Capital announced today the appointment of Zach Hitchcock as a Managing Director. Zach will lead the firm’s coverage efforts in New York City, focusing on expanding Arcadia’s global tech and tech services expertise and building on its existing advisory capabilities across the ecosystem. Zach joins Arcadia Capital with more than 10 years of experience in strategic M&A, growth capital advisory, and principal investing within the technology sector. Most recently...

NEW YORK--(BUSINESS WIRE)--Institutional investors holding positions in Concorde International Group, Ltd. (NASDAQ: CIGL) during the Class Period of April 21, 2025, through July 14, 2025, may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. CIGL shares collapsed from a Class Period high of $31.06 to approximately $2.00, rep...

NEW YORK--(BUSINESS WIRE)--Institutional investors holding positions in Hercules Capital, Inc. (NYSE: HTGC) during the period from May 1, 2025 through February 27, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. Hercules Capital managed over $5.7 billion in assets as of December 31, 2025, making it a significant h...

DALLAS--(BUSINESS WIRE)--Expedition:Earth, a Texas-based multi-brand operator in high-end personalized experiential travel, announced a strategic investment in Iconic Adventures. Iconic is a Steamboat Springs, CO-based tour operator specializing in ultra-high-end bespoke travel experiences for corporate clients, non-profit organizations, universities, family offices, and FIT clients across five continents. This transaction represents Expedition:Earth's second platform partnership and further ad...

NEW YORK--(BUSINESS WIRE)--The artificial intelligence server market attracted tens of billions in capital as investors poured into companies powering next-generation AI infrastructure. Super Micro Computer, Inc. (NASDAQ: SMCI) rode this wave to nearly $15 billion in fiscal 2024 revenue and $22 billion in fiscal 2025, but a federal indictment now alleges approximately $2.5 billion of those sales were illegal. Levi & Korsinsky, LLP notifies investors in Super Micro Computer, Inc. (NASDAQ: SMC...

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies investors that Jeremy J. Heaton, former Chief Financial Officer of Alight, Inc. (NYSE: ALIT), is named as an individual defendant in a securities class action filed in the United States District Court for the Northern District of Illinois. The action covers purchases between November 12, 2024 and February 18, 2026. Find out if you are entitled to recover investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsin...

NEW YORK--(BUSINESS WIRE)--"We firmly believe that we have accomplished this patient selection goal." That was the promise. The reality: a Phase 3 trial that failed its primary endpoint, and shareholders who lost over 80% of their investment in a single trading session.Levi & Korsinsky, LLP notifies investors in Gossamer Bio, Inc. (NASDAQ: GOSS) that a securities class action has been filed on behalf of purchasers who acquired GOSS stock between June 16, 2025 and February 20, 2026. Find out...

NEW YORK--(BUSINESS WIRE)--Institutional investors holding positions in ImmunityBio, Inc. (NASDAQ: IBRX) during the period January 19, 2026 through March 24, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Shares lost $1.98 per share, a 21% decline, after an FDA Warning Letter exposed allegedly false promotional claims about the Company's lead drug, ANKTIVA. Request an institutional investor loss assessment or contact Joseph E. Levi, Esq. at jlevi@lev...

NEW YORK--(BUSINESS WIRE)--Institutional investors holding positions in Coty Inc. (NYSE: COTY) during the period November 5, 2025 through February 4, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. Coty shares fell from $3.43 to $2.66 per share, a cumulative decline of approximately 22%, after the Company withdrew...